<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2341-4545</journal-id>
<journal-title><![CDATA[GE-Portuguese Journal of Gastroenterology]]></journal-title>
<abbrev-journal-title><![CDATA[GE Port J Gastroenterol]]></abbrev-journal-title>
<issn>2341-4545</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Gastrenterologia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2341-45452021000400284</article-id>
<article-id pub-id-type="doi">10.1159/000510578</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[The Coronavirus Chasm in Inflammatory Bowel Disease: Report of Patient-Centered Care at a Hospital in Northern Portugal]]></article-title>
<article-title xml:lang="pt"><![CDATA[O abismo do Coronavírus na Doença Intestinal Inflamatória: Experiência de um Hospital no Norte de Portugal em cuidados centrados no doente]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lago]]></surname>
<given-names><![CDATA[Paula]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caetano]]></surname>
<given-names><![CDATA[Cidalina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[Daniela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salgado]]></surname>
<given-names><![CDATA[Marta]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pedroto]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Hospitalar Universitário do Porto Hospital Santo António Department of Gastroenterology]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,University of Porto Abel Salazar Institute of Biomedical Sciences (ICBAS), ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>08</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>08</month>
<year>2021</year>
</pub-date>
<volume>28</volume>
<numero>4</numero>
<fpage>284</fpage>
<lpage>287</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2341-45452021000400284&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2341-45452021000400284&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2341-45452021000400284&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction: Although patient-centered care can be found in the mission statement of nearly every hospital, it is not always put into practice, and COVID-19 brings new challenges even to the best-organized hospitals and well-developed health care systems.  Methods: In the current COVID-19 pandemic, inflammatory bowel disease (IBD) patients have a potentially higher risk of complications from this infectious disease due to the use of immunosuppressant and/or biologic treatments and due to flares of this chronic illness, which often require urgent care and sometimes hospitalization. Moreover, patients undergoing biologic intravenous (IV) treatment visit the hospital for scheduled IV infusions.  Discussion: In hospitals like ours, where COVID-19 patients are treated, the organization of &#8220;clean circuits&#8221; is essential to minimize the risks of infection for non-COVID-19 patients, such as patients in IBD infusion units. In our hospital, the IBD infusion unit is located within the gastroenterology department, which, under normal circumstances, is very advantageous for patients but in the current context is not. Our goal was to maximize adherence to biologic IV treatment and clinical safety at a time of profound changes in gastroenterology activity and in a department with daily increases in the number of COVID-19 patients.  Conclusion: To this end, we initiated proactive COVID-19 testing in IBD patients undergoing biologic IV treatment and changed the location of the infusion unit to a &#8220;COVID-free&#8221; institution, maintaining the care of these patients by the dedicated IBD team of our department. The purpose of this report is to show that a patient-centered care strategy allowed us to reach very high levels of patient comfort, satisfaction, and compliance with therapeutics.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  Os cuidados centrados no doente são uma intenção de quase todas as declarações de missão de um hospital. No entanto, nem sempre são colocados em prática. A doença por COVID-19 trouxe novos desafios, mesmo para os hospitais mais bem organizados e com sistemas de saúde desenvolvidos.  Métodos: Na atual pandemia COVID-19, os doentes com doença intestinal inflamatória (DII), têm um risco potencialmente maior de complicações desta doença infeciosa, quer pelo uso de tratamentos imunossupressores e/ou biológicos, quer pela natureza crónica da doença, que evolui com agudizações, que frequentemente requerem cuidados urgentes e, às vezes, hospitalização. Os doentes sob biológicos intravenosos (IV) necessitam de recorrer ao hospital para infusão programada.  Discussão: Em hospitais como o nosso, onde doentes com COVID-19 são recebidos e tratados, a organização de &#8220;circuitos limpos&#8221; é essencial para minimizar os riscos de infeção em doentes não-COVID-19, nomeadamente nas unidades de infusão de biológicos. No nosso Hospital, a unidade de infusão localiza-se dentro do Departamento de Gastrenterologia, o que em circunstâncias normais é muito vantajoso para os doentes, mas não o foi no contexto da atual pandemia. O nosso objetivo, num momento de profunda mudança da atividade da Gastrenterologia e num Departamento com aumento diário do número de doentes COVID-19, foi o de maximizar a adesão aos tratamentos biológicos IV e a sua segurança clínica.  Conclusão: Para isso iniciamos um programa proactivo de teste a COVID-19, nos doentes com DII, sob biológicos IV, e mudamos a unidade de infusão para uma Instituição &#8220;COVID free,&#8221; mantendo a habitual orientação destes doentes pela equipe diferenciada de DII do nosso Serviço. O objetivo deste trabalho é mostrar que, com uma estratégia de cuidados centrados no doente, foi possível atingir níveis elevados de adesão à terapêutica, de conforto e satisfação.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[Inflammatory bowel disease]]></kwd>
<kwd lng="en"><![CDATA[Patient-centered care]]></kwd>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[Doença intestinal inflamatória]]></kwd>
<kwd lng="pt"><![CDATA[Cuidados centrados no doente]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Institute of Medicine (US) Committee on Quality of Health Care in America</collab>
<source><![CDATA[Crossing the Quality Chasm: A New Health System for the 21st Century]]></source>
<year>2001</year>
<publisher-loc><![CDATA[Washington (DC) ]]></publisher-loc>
<publisher-name><![CDATA[National Academies Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vanhaecht]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Panella]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Van Zelm]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Sermeus]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is there a future for pathways? Five pieces of the puzzle]]></article-title>
<source><![CDATA[Int J Care Pathways]]></source>
<year>2009</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>82-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubin]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Abreu]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Rai]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Ahuja]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Allez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of patients with Crohn&#8217;s disease and ulcerative colitis during the COVID-19 pandemic: results of an international meeting]]></article-title>
<collab>International Organization for the Study of Inflammatory Bowel Disease</collab>
<source><![CDATA[Gastroenterology]]></source>
<year>2020</year>
<volume>159</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-13</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
